Immunogenicity and safety of inactivated whole virion Coronavirus vaccine with CpG (VLA2001) in healthy adults aged 18 to 55: a randomised phase 1 /2 clinical trial

Rajeka Lazarus, Christian Taucher, Claire Brown, Irena Corbic, Leon Danon, Katrin Dubischar, Christopher J.A. Duncan, Susanne Eder-Lingelbach, Saul N Faust, Christopher Green, Karishma Gokani, Romana Hochreiter, Johanna Kellett Wright, Dowan Kwon, Alexander Middleditch, Alasdair P.S. Munro, Kush Naker, Florentina Penciu, David Price, Benedicte Querton, Tawassal Riaz, Amy Ross-Russell, Amada Sanchez-Gonzalez, Hayley Wardle, Sarah Warren, Adam Finn, the Valneva Phase 1 Trial Group
doi: https://doi.org/10.1101/2021.08.13.21262021

Article Information

doi 
https://doi.org/10.1101/2021.08.13.21262021
History 
  • August 20, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Rajeka Lazarus, DPhil1,*,
  2. Christian Taucher, PhD2,*,&,
  3. Claire Brown, BSc3,
  4. Irena Corbic, PhD2,
  5. Leon Danon, PhD4,
  6. Katrin Dubischar, MSc2,
  7. Christopher J.A. Duncan, DPhil5,
  8. Susanne Eder-Lingelbach, MSc2,
  9. Prof Saul N Faust, PhD6,
  10. Christopher Green, DPhil3,
  11. Karishma Gokani, MBBS3,
  12. Romana Hochreiter, PhD2,
  13. Johanna Kellett Wright, MBBS1,
  14. Dowan Kwon, MBChB1,
  15. Alexander Middleditch, FFICM1,
  16. Alasdair P.S. Munro, MRCPCH6,
  17. Kush Naker, MSc3,
  18. Florentina Penciu, MD1,
  19. David Price, MD5,
  20. Benedicte Querton2,
  21. Tawassal Riaz, MBBS1,
  22. Amy Ross-Russell, MRCP,
  23. Amada Sanchez-Gonzalez, MBBS,
  24. Hayley Wardle, MB ChB,
  25. Sarah Warren, MBBS, PhD6,
  26. Prof Adam Finn, PhD1,7,
  27. the Valneva Phase 1 Trial Group
  1. 1University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK
  2. 2VALNEVA AUSTRIA GMBH, Vienna, Austria
  3. 3NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  4. 4Department of Engineering Mathematics, University of Bristol, Bristol, UK
  5. 5Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust; Translational and Clinical Research Institute, Immunity and Inflammation Theme, Newcastle, UK
  6. 6NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust; and Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK
  7. 7Schools of Population Health Sciences and Cellular and Molecular Medicine, University of Bristol, Bristol UK
  1. ↵&Corresponding author: Christian Taucher, christian.taucher{at}valneva.com

  1. ↵* Contributed equally

Back to top
Posted August 20, 2021.
Download PDF
Data/Code
Email
Immunogenicity and safety of inactivated whole virion Coronavirus vaccine with CpG (VLA2001) in healthy adults aged 18 to 55: a randomised phase 1 /2 clinical trial
Rajeka Lazarus, Christian Taucher, Claire Brown, Irena Corbic, Leon Danon, Katrin Dubischar, Christopher J.A. Duncan, Susanne Eder-Lingelbach, Saul N Faust, Christopher Green, Karishma Gokani, Romana Hochreiter, Johanna Kellett Wright, Dowan Kwon, Alexander Middleditch, Alasdair P.S. Munro, Kush Naker, Florentina Penciu, David Price, Benedicte Querton, Tawassal Riaz, Amy Ross-Russell, Amada Sanchez-Gonzalez, Hayley Wardle, Sarah Warren, Adam Finn, the Valneva Phase 1 Trial Group
medRxiv 2021.08.13.21262021; doi: https://doi.org/10.1101/2021.08.13.21262021
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area